NYSE:DHRLife Sciences
Masimo Deal Approval Sets Stage For Danaher Growth And Valuation Re‑Rating
Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR).
The vote clears a key milestone for the acquisition and allows the deal process to move toward closing.
The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met.
For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...